Abstract |
Some 86 heart transplant recipients under immunosuppressive therapy were vaccinated against hepatitis B using the vaccine Gen H-B-Vax-D, but 95.3% failed to develop protective levels of HBs-specific antibody (more than 10 U/l) after the third vaccination.
|
Authors | D Wagner, I Wagenbreth, R Stachan-Kunstyr, J Flik |
Journal | The Clinical investigator
(Clin Investig)
Vol. 70
Issue 7
Pg. 585-7
(Jul 1992)
ISSN: 0941-0198 [Print] Germany |
PMID | 1392427
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Female
- Heart Transplantation
- Hepatitis B
(epidemiology, etiology, prevention & control)
- Hepatitis B Vaccines
- Humans
- Immunocompromised Host
- Immunosuppression Therapy
(adverse effects)
- Male
- Middle Aged
- Postoperative Complications
(epidemiology, etiology, prevention & control)
- Transfusion Reaction
- Vaccination
|